There is no really safe amount of endocrine disruptors
In a moment when trust in public institutions is already fragile, the Trump administration declared hundreds of baby formula samples safe — yet independent scientists reading the same data found widespread contamination with chemicals known to disrupt human development at any dose. The distance between an official reassurance and a scientific reckoning is rarely more consequential than when the ones most at risk are newborns, whose bodies are still becoming. What is at stake here is not merely a regulatory dispute, but the question of who gets to define safety, and for whom.
- The FDA tested 300 baby formula samples and found PFAS in the majority and phthalates in roughly half — chemicals with no established safe exposure level for infants — yet the administration publicly declared most products met safety standards.
- Independent scientists warn that the official framing obscures the danger: endocrine-disrupting chemicals can alter hormonal development at critical windows, with consequences that may not surface until years after exposure.
- The FDA's public data withholds product names, omits whether individual samples carried multiple contaminants, and ignores the compounding risk of chemical mixtures — leaving parents with reassurance but no actionable information.
- Dry formulas mixed with PFAS-contaminated tap water may double infants' exposure, and short-chain PFAS compounds — now pervasive throughout the food system — are turning up precisely because of how widely they are used in manufacturing.
- Experts are calling for enforceable lead action levels, mandatory disclosure of manufacturer testing, and sustained monitoring — warning that a single-snapshot study followed by a safety declaration offers no guarantee contamination won't quietly return.
When the Trump administration announced in early May that hundreds of baby formula samples had cleared a high safety bar, the declaration carried official weight. HHS Secretary Robert F. Kennedy Jr. promised parents honest, trustworthy data. But independent scientists who examined the actual results from the FDA's Operation Stork Speed saw something different.
The testing covered 300 samples across a range of contaminants — PFAS, phthalates, lead, pesticides, mercury. What it found was widespread: at least half the samples contained PFOS, among the most hazardous PFAS compounds, and roughly half contained phthalates, plasticizers that leach from plastic packaging. Some samples showed lead; others contained chlorpyrifos, a pesticide the EPA had attempted to ban. Independent regulatory consultant Maricel Maffini said she was alarmed by the prevalence of endocrine-disrupting chemicals — substances that can interfere with hormonal development at critical stages, with effects that may not appear for years. "There is no really safe amount of endocrine disruptors," she said.
The FDA's framing of the PFAS data illustrated the gap. The agency highlighted that 25 of 30 tested PFAS compounds were absent from all samples — a statistic designed to reassure. But a majority of samples still contained some PFAS. Environmental Working Group scientist Tasha Stoiber noted that much of the contamination appeared in dry formulas, which parents mix with water that may itself carry PFAS — compounding the exposure before a single feeding.
Critical transparency failures compounded the concern. Product names were withheld, so parents could not identify safer options. The FDA did not disclose whether individual samples contained multiple contaminants simultaneously, even though scientists expect chemical mixtures to carry additive or synergistic risks. This stood in tension with the FDA's own 2014 internal paper, which had detailed the particular vulnerability of newborns — their higher food-to-body-weight ratios and still-developing systems making them far more susceptible than adults.
Tom Neltner of the Unleashed Kids nonprofit acknowledged that lead levels had improved compared to prior years — evidence that pressure on manufacturers can work. But he warned that progress without ongoing oversight is fragile. Manufacturers routinely test their own formulas, yet the FDA claims limited authority to access those results — a claim Neltner disputed. New legislation in California and Vermont would require public disclosure of that testing. His central demand: the FDA must establish an enforceable action level for lead. "The next step can't be to declare it safe," he said, "because there is no assurance that companies will keep it at these levels."
In early May, the Trump administration announced that hundreds of baby formula samples tested for toxic chemicals had cleared a high safety bar. The claim landed with official weight: the Department of Health and Human Services secretary, Robert F. Kennedy Jr., declared that most products met safety standards, and promised parents honest data they could trust. But independent scientists who examined the actual test results saw something different in the numbers.
The FDA's Operation Stork Speed had tested 300 baby formula samples for PFAS, phthalates, lead, pesticides, mercury, and other dangerous substances. The contamination was widespread. At least half the samples contained PFOS, one of the most hazardous PFAS compounds—a chemical for which the federal government had previously determined no safe level exists in drinking water. About half also contained phthalates, plasticizers that leach from plastic packaging and processing equipment. Several samples showed lead. Some contained chlorpyrifos, a pesticide the EPA had tried to ban in 2021 before industry mounted a successful legal challenge.
The gap between the administration's framing and what the data actually showed troubled experts. Maricel Maffini, an independent regulatory consultant, said she was alarmed by how prevalent these endocrine-disrupting chemicals were. The concern isn't abstract: these substances can alter children's hormones at critical developmental windows, potentially causing developmental, reproductive, and neurological harm that may appear immediately or years later. "There is no really safe amount of endocrine disruptors," Maffini said. The prevailing argument that low doses pose minimal risk, she added, contradicts what science actually knows about how these chemicals work in the body.
The FDA's own framing of the PFAS results illustrated the problem. The agency noted that 25 of 30 PFAS compounds tested were not found in any samples—a statistic designed to sound reassuring. But a majority of samples still contained some PFAS, and at levels that concerned independent researchers. The drinking water limit for PFOS is set at four parts per trillion, yet 95 percent of the formula samples tested fell below 2.9 parts per trillion. Public health advocates pointed out that drinking water standards may not even be protective enough for infants, whose smaller bodies and developing systems make them far more vulnerable than adults.
Tasha Stoiber, a scientist with the Environmental Working Group, noted that much of the PFAS contamination appeared in dry formulas, which parents mix with water—water that itself may contain PFAS, compounding the exposure. The chemicals found were the short-chain varieties now used throughout the food system. "When there is widespread use of PFAS, this is the result," Stoiber said.
Critical gaps riddled the FDA's public data. Product names were not disclosed, leaving parents unable to identify which formulas were free from contamination. The agency did not report whether individual samples contained multiple contaminants. Though research on combined chemical exposure remains limited, scientists generally expect such mixtures to have additive or synergistic effects—making them more dangerous than any single chemical alone. The FDA's 2014 internal paper had detailed how small amounts of these very chemicals posed serious risks to newborns with their higher food-to-body-weight ratios and still-developing systems. Yet the administration's current statements seemed to contradict that earlier assessment.
Tom Neltner, director of the Unleashed Kids nonprofit, praised the expanded testing but warned that a single snapshot was insufficient. Lead contamination, historically a persistent problem in baby formula, showed improvement in these tests compared to past years—evidence that public and political pressure on manufacturers could work. But that progress could evaporate without ongoing oversight. "We need ongoing transparency," Neltner said. He noted that manufacturers regularly test their own formulas but the FDA claims it largely lacks authority to view those results—a claim Neltner disputed. New legislation in California and Vermont would require producers to share their testing publicly. The FDA's next move, Neltner argued, must be to set an enforceable action level for lead, which does not yet exist. "The next step can't be to declare it safe, because there is no assurance that companies will keep it at these levels," he said.
Notable Quotes
There is no really safe amount of endocrine disruptors. It seems the overarching argument is that in low amounts they don't do anything, but that goes against everything we know about how these chemicals impact the body.— Maricel Maffini, independent regulatory consultant
We need ongoing transparency. The next step can't be to declare it safe, because there is no assurance that companies will keep it at these levels.— Tom Neltner, director of Unleashed Kids nonprofit
The Hearth Conversation Another angle on the story
When the administration says these formulas "meet a high safety standard," what are they actually measuring against?
That's the core problem. They're comparing against their own thresholds, not against what independent science says is actually safe for newborns. The drinking water standard for PFOS is four parts per trillion, but these formulas are at 2.9—which sounds better until you realize infants aren't adults. Their bodies are smaller, their organs are still forming, and they drink formula as their entire diet.
So the contamination is real, but the question is whether it matters at these levels?
Exactly. And the experts say yes, it matters. Especially with endocrine disruptors like phthalates and PFAS. These chemicals work differently than poisons that have a threshold below which they're harmless. At low doses, they can still alter hormone development in ways that show up later—reproductive problems, neurological issues, weakened immunity.
Why aren't product names listed in the results?
That's the transparency problem. Parents can't actually know which formulas to avoid or choose. And the FDA didn't say if a sample had one contaminant or five. If a baby is drinking formula with PFAS and phthalates and lead all together, that's different than one alone, but we don't know.
What would actually make this safe?
Enforceable limits on phthalates—the FDA hasn't set any. Action levels for lead. And mandatory disclosure of what manufacturers find in their own testing. Right now it's voluntary, and the FDA says it can't even see most of it.
Is the administration's testing a step forward, then?
Yes and no. The testing itself is good—more than ever before. But announcing the results as reassuring when the data shows half the samples contaminated with dangerous chemicals? That's where trust breaks down.